These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7226371)

  • 41. A trial of 'lacribase', a new ophthalmic vehicle.
    Maclure GM
    Br J Clin Pract; 1967 Aug; 21(8):397-400. PubMed ID: 6076263
    [No Abstract]   [Full Text] [Related]  

  • 42. Pemphigoid related to epinephrine treatment.
    Norn MS
    Am J Ophthalmol; 1977 Jan; 83(1):138. PubMed ID: 319673
    [No Abstract]   [Full Text] [Related]  

  • 43. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Keratitis due to prolonged use of anesthetic eyedrops; apropos of 3 new cases].
    Couderc JL; Hamard H; D'Esperey-Fougeres R; Bregeat P
    Bull Soc Ophtalmol Fr; 1975 Jan; 75(1):31-5. PubMed ID: 1204147
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effectiveness, tolerance and acceptance of polyvidon preparations].
    Höh H; Fink R; Dehnicke C; Klöcker N
    Klin Monbl Augenheilkd; 1999 Oct; 215(4):A8-14. PubMed ID: 10572880
    [No Abstract]   [Full Text] [Related]  

  • 46. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment.
    Hall VC; Liesegang TJ; Kostick DA; Lookingbill DP
    Arch Dermatol; 2003 Aug; 139(8):1083-4. PubMed ID: 12925404
    [No Abstract]   [Full Text] [Related]  

  • 47. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
    Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
    Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anterior segment complications following periocular and intraocular injections.
    Castellarin A; Pieramici DJ
    Ophthalmol Clin North Am; 2004 Dec; 17(4):583-90, vii. PubMed ID: 15533752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic reactions associated with ophthalmic medications.
    Lama PJ
    Ophthalmol Clin North Am; 2005 Dec; 18(4):569-84. PubMed ID: 16314220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro interferon-gamma release test in patients with drug-induced pemphigus.
    Goldberg I; Shirazi I; Brenner S
    Isr Med Assoc J; 2008 Jun; 10(6):424-7. PubMed ID: 18669138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drugs and the eye].
    Hoang-Xuan T; Bouder P
    Rev Prat; 1994 Feb; 44(3):415-8. PubMed ID: 7909955
    [No Abstract]   [Full Text] [Related]  

  • 52. [Local anesthesia of the cornea. Risks with self-application].
    Naess K
    Tidsskr Nor Laegeforen; 1971 Dec; 91(34):2508-9. PubMed ID: 5139131
    [No Abstract]   [Full Text] [Related]  

  • 53. Ringer's solution with pseudomonas.
    Worst JG
    J Am Intraocul Implant Soc; 1978 Jan; 4(1):68-9. PubMed ID: 701155
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hazards of local anesthetics in ophthalmology].
    Loos E
    Bull Soc Sci Med Grand Duche Luxemb; 1977 May; 114(1):29-32. PubMed ID: 890879
    [No Abstract]   [Full Text] [Related]  

  • 55. [D-penicillamine-induced pemphigus].
    Chouvet B; Thivolet J; Bathias J; Forestier JY
    Dermatologica; 1980; 160(5):297-310. PubMed ID: 7364140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Induced pemphigus and genetic predisposition. Apropos of 3 clinical cases].
    Pisani M; Ruocco V; Magrì D
    G Ital Dermatol Venereol; 1986; 121(1):39-43. PubMed ID: 3084379
    [No Abstract]   [Full Text] [Related]  

  • 57. Ocular drug abuse in Lagos, Nigeria.
    Adefule-Ositelu AO
    Acta Ophthalmol (Copenh); 1989 Aug; 67(4):396-400. PubMed ID: 2801041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Drug-induced pemphigus: clinical review and pathogenic mechanism].
    Civatte J
    Bull Acad Natl Med; 1986 Nov; 170(8):1057-63. PubMed ID: 3552140
    [No Abstract]   [Full Text] [Related]  

  • 59. Ocular involvement in pemphigus.
    Palleschi GM; Giomi B; Fabbri P
    Am J Ophthalmol; 2007 Jul; 144(1):149-52. PubMed ID: 17601446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-medicated over the counter ophthalmic solutions in central Bangkok.
    Tayanithi P; Aramwit P
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S330-4. PubMed ID: 16623050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.